On May 11, 2018 a
Exhibit,Appendix
was filed
involving a dispute between
Cresco Labs Llc, An Illinois Limited Liability Company,
Cresco Labs New York, Llc,
A New York Limited Liability Company,
and
Eric Sirota,
Fiorello Pharmaceuticals, Inc.,
A New York Corporation,
John Does 1 - 10,
Susan Yoss,
for Commercial Division
in the District Court of New York County.
Preview
FILED: NEW YORK COUNTY CLERK 01/06/2022 11:03 PM INDEX NO. 652343/2018
NYSCEF DOC. NO. 389 RECEIVED NYSCEF: 12/02/2022
EXHIBIT 45
Document showing the owners' interests in preferred
shareholder NYS Pharmaceuticals
Index No. 652343/2018
FILED: NEW YORK COUNTY CLERK 01/06/2022 11:03 PM INDEX NO. 652343/2018
NYSCEF DOC. NO. 389 RECEIVED NYSCEF: 12/02/2022
NYS Pharmaceuticals Investors LLC
Address: 411 West End Avenue, Apt 6D, New York, NY 10024
Primary activities: Investment in Fiorello Pharmaceuticals, Inc.
Interest in applicant: NYS Pharmaceuticals Investors, LLC which owns shares of preferred stock
convertible into common stock of Fiorello Pharmaceuticals, Inc. comprising approximately 7%
ownership interest in the Company.
Extent to which the entity will be involved in the applicant's activities and/or responsible for the
applicant's financial and contractual obligations:
NYS Pharmaceuticals Investors LLC will not be involved in Fiorello's activities or responsible for its
financial or contractual obligations.
Original Application Organizational and Operational Documents (Section H, Exhibit 1, Page
1A.00115):
" NYS Pharmaceuticals Investors LLC Certificate of Formation
" NYS Pharmaceuticals Investors Agreement
Operating
" NYS Pharmaceuticals Investors Updated Agreement (included in
Operating
current submission)
Identification of all owners and their interests:
" Sandra Canarick- 4.26%
" Jonathan Canarick - 4.26%
" The ASR Revocable Trust - 8.51%
Living
" Evan Seidenstein- 8.51%
" Daniel Mark Siegel - 18.72%
" Lori Miele - 8.51%
" Daniel Canarick- 2.13%
" Brian Stern- 4.26%
" David Weston- 2.56%
" Mark Hayden - 4.26%
" Andrew Stone - 25.5%
" Lawrence - 4.26%
Shelley
" Kenneth Kornblau - 4.26%
CONFIDENTIAL D003473
Document Filed Date
January 06, 2022
Case Filing Date
May 11, 2018
Category
Commercial Division
For full print and download access, please subscribe at https://www.trellis.law/.
Preview
FILED: NEW YORK COUNTY CLERK 01/06/2022 11:03 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 389 RECEIVED NYSCEF: 12/02/2022 EXHIBIT 45 Document showing the owners' interests in preferred shareholder NYS Pharmaceuticals Index No. 652343/2018 FILED: NEW YORK COUNTY CLERK 01/06/2022 11:03 PM INDEX NO. 652343/2018 NYSCEF DOC. NO. 389 RECEIVED NYSCEF: 12/02/2022 NYS Pharmaceuticals Investors LLC Address: 411 West End Avenue, Apt 6D, New York, NY 10024 Primary activities: Investment in Fiorello Pharmaceuticals, Inc. Interest in applicant: NYS Pharmaceuticals Investors, LLC which owns shares of preferred stock convertible into common stock of Fiorello Pharmaceuticals, Inc. comprising approximately 7% ownership interest in the Company. Extent to which the entity will be involved in the applicant's activities and/or responsible for the applicant's financial and contractual obligations: NYS Pharmaceuticals Investors LLC will not be involved in Fiorello's activities or responsible for its financial or contractual obligations. Original Application Organizational and Operational Documents (Section H, Exhibit 1, Page 1A.00115): " NYS Pharmaceuticals Investors LLC Certificate of Formation " NYS Pharmaceuticals Investors Agreement Operating " NYS Pharmaceuticals Investors Updated Agreement (included in Operating current submission) Identification of all owners and their interests: " Sandra Canarick- 4.26% " Jonathan Canarick - 4.26% " The ASR Revocable Trust - 8.51% Living " Evan Seidenstein- 8.51% " Daniel Mark Siegel - 18.72% " Lori Miele - 8.51% " Daniel Canarick- 2.13% " Brian Stern- 4.26% " David Weston- 2.56% " Mark Hayden - 4.26% " Andrew Stone - 25.5% " Lawrence - 4.26% Shelley " Kenneth Kornblau - 4.26% CONFIDENTIAL D003473